Latest from NIDA

Higher rate of substance use among Native American youth on reservations

May 31, 2018 | A survey comparing drug use among Native American youth living on or near reservations to a national sample of American youth found that Native American youth report substantially higher use...

Science Highlight

Breathing under the influence of … fentanyl

May 30, 2018 | An animal study at NIDA's intramural research labs suggests fentanyl-induced respiratory depression affects the temperature of the brain, triggering brain hypoxia and hyperglycemia.

News Release

Method to identify undetected drug suicides wins top NIDA Addiction Science Award

May 18, 2018 | A project that identified and tested a bioinformatics program that can help identify underreported suicides linked to drug overdoses was awarded the first-place distinction at the 2018 Intel International Science...

News Release

FDA approves first medication to reduce opioid withdrawal symptoms

May 16, 2018 | Lofexidine, the first medication for use in reducing symptoms associated with opioid withdrawal in adults, has been approved by the U.S. Food and Drug Administration.

Science Highlight

What science says about Tobacco + Marijuana + Pregnancy

May 11, 2018 | A NIDA-funded study suggests that pregnant women who smoke both marijuana and cigarettes have a higher likelihood of smaller babies and increased maternal stress and aggression.

News Release

Study upends conventional view of opioid mechanism of action

May 10, 2018 | A new discovery shows that opioids used to treat pain, such as morphine and oxycodone, produce their effects by binding to receptors inside neurons, contrary to conventional wisdom that they...

NIDA Notes

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 3

May 4, 2018 | Dr. Linda Dwoskin feels just one small step away from success in her effort to develop the first-ever medication to treat methamphetamine addiction. She and colleagues at the Universities of...

News Release

Nearly half of opioid-related overdose deaths involve fentanyl

May 1, 2018 | An analysis of opioid-related overdose deaths found that synthetic opioids, such as illicit fentanyl, have surpassed prescription opioids as the most common drug involved in overdose deaths in the U.S.

News Release

Dr. Kurt Rasmussen to lead NIDA’s therapeutics and medical consequences division

April 30, 2018 | The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, welcomed Dr. Kurt Rasmussen today as the Director of the Division of Therapeutics and Medical...

News Release

Understanding the Neuroscience of Addiction: what it means for prevention and treatment

April 25, 2018 | Advances in the understanding of brain development, as well as the role that genes and environment play in addiction, are the focus of a review article published today in The...

NIDA Notes

Fear of Distress Signals Risk for Opioid Misuse in Chronic Pain Patients

April 24, 2018 | In this research: Among patients with chronic pain, those who reported less ability to tolerate physical or emotional distress were more likely to misuse opioid analgesics. Neither pain severity nor...

Science Highlight

Overdose drug shows promise as stroke treatment

April 17, 2018 | Preclinical research lays the groundwork for developing the first drug to promote recovery from ischemic stroke, a leading cause of adult disability.

News Release

Five million American adults misusing prescription stimulants

April 16, 2018 | Looking at annual averages, approximately 6.6% (or 16 million) of U.S. adults used prescription stimulants in the preceding year; 4.5% (or 11 million) used prescription stimulants appropriately (without misuse); 2.1%...

Science Highlight

Communities That Care program shows success in reducing substance use and behavioral issues in adolescents

April 13, 2018 | The CTC is a prevention planning and implementation system that trains community coalition is to assess their community’s needs, then select and use evidence-based programs and policies to reduce risk...

News Release

Study changes long-held concepts of cell decoding

March 28, 2018 | Scientists at the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) have uncovered evidence that shows a more complex and elaborate role for the body's hard-working G protein-coupled...

Science Highlight

Study highlights how opioid receptors organize to block pain

March 27, 2018 | A NIDA-funded study explored how opioids such as morphine act within pain circuits in the brain and spinal cord, while attaching to receptors on the surface of nerve cells (neurons).

News Release

E-cigarette ads associated with cigarette smoking initiation among youth

March 26, 2018 | A scientific study finds that receptivity to e-cigarette advertising increases the likelihood of trying conventional cigarettes one year later.

News Release

Non-psychoactive cannabinoid may enable drug addiction recovery

March 26, 2018 | Cannabidiol (CBD), a non-psychoactive chemical found in marijuana, may help reduce the risk of drug and alcohol relapse.

Science Highlight

Gut-brain axis offers clues to treatments for addictive disorders

March 15, 2018 | Scientists have investigated how the stomach-derived hormone ghrelin affects alcohol-seeking behaviors, discovering for the first time in humans that administration of ghrelin intravenously significantly increased alcohol intake in heavy drinking...

News Release

Higher rate of substance use among Native American youth on reservations

Breathing under the influence of … fentanyl

Method to identify undetected drug suicides wins top NIDA Addiction Science Award

FDA approves first medication to reduce opioid withdrawal symptoms

What science says about Tobacco + Marijuana + Pregnancy

Study upends conventional view of opioid mechanism of action

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 3

Nearly half of opioid-related overdose deaths involve fentanyl

Dr. Kurt Rasmussen to lead NIDA’s therapeutics and medical consequences division

Understanding the Neuroscience of Addiction: what it means for prevention and treatment

Fear of Distress Signals Risk for Opioid Misuse in Chronic Pain Patients

Overdose drug shows promise as stroke treatment

Five million American adults misusing prescription stimulants

Communities That Care program shows success in reducing substance use and behavioral issues in adolescents

Study changes long-held concepts of cell decoding

Study highlights how opioid receptors organize to block pain

E-cigarette ads associated with cigarette smoking initiation among youth

Non-psychoactive cannabinoid may enable drug addiction recovery

Gut-brain axis offers clues to treatments for addictive disorders

NIDA's 2018 Avant-Garde awards highlight immune response and killer cells

Stimulating news about brain glutamate

Why Marijuana Displeases

Teens, E-Cigs and Toxins?

Repurposed arthritis drug could become a non-opioid pain reliever

The brain's hyper-network uncovered

Neuronal ensembles take center stage

Greek life membership associated with binge drinking and marijuana use in later life

Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release

NIH releases first dataset from unprecedented study of adolescent brain development

Long-Term Marijuana Use Is Associated With Health Problems Later in Life